Clinical Trials Insight: 700035680
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2009
At a glance
- Drugs Adenosine triphosphate (Primary)
- Indications Paroxysmal supraventricular tachycardia
- Focus Registrational; Therapeutic Use
- Sponsors Cordex Pharma
- 02 Jun 2009 Status changed from planning to not yet recruiting, according to a Cordex Pharma media release.
- 18 Feb 2009 Amended phase III protocol submitted to FDA, according to a media release from Cordex Pharma.
- 20 Nov 2008 According to a Duska Therapeutics media release, this trial is expected to commence in quarter 1 of 2009.